BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 29, 2001
View Archived Issues
Enrollment closed in Atrix's phase III trial with four-month Leuprogel
Read More
Arena and Taisho establish receptor discovery alliance
Read More
Dey receives FDA approval for first dual-therapy nebulizer solution for use in COPD
Read More
InterMune and Boehringer Ingelheim establish codevelopment agreement for interferon gamma-1b
Read More
Intravenous formulation of Protonix approved by FDA for GERD
Read More
PAK-200 shows cardioprotective effects in guinea pig myocardium
Read More
Mechanism of gastroprokinetic effects of Z-338 discussed at recent scientific meeting
Read More
Progen and Griffith University to discover new compounds to treat inflammatory diseases
Read More
BioChem Pharma's Troxatyl enters late-stage clinical trials in AML patients
Read More
Abgenix and Diabetogen collaborate on development of anti-CD28 antibody therapy
Read More
AtheroGenics commences phase I trial with AGIX-4207 for treatment of RA
Read More
MoliChem's aerosol product for CF undergoes phase Ib clinical trials
Read More
Profile, status of Lorus's lead cancer therapeutics discussed at AACR meeting
Read More
Antitumor and antiangiogenic effects demonstrated for new VEGF-binding molecule
Read More
Peptidomimetic and small-molecule uPA inhibitors hold promise as cancer therapeutics
Read More
German launch of antimigraine Almogran imminent
Read More
Johnson & Johnson and Alza agree to merge
Read More
ROCK inhibitors investigated for potential as antiglaucoma drugs
Read More
Recently approved IOP-lowering prostaglandin highlighted at Prague glaucoma meeting
Read More
Ciclesonide to be codeveloped and copromoted by Aventis and Altana for asthma
Read More
Replagal receives positive opinion in E.U. for treatment of Fabry's disease
Read More
Camptosar approved in Canada as first-line treatment of metastatic colorectal cancer
Read More
Tryptase inhibitors and use in respiratory disorders claimed by Byk Gulden
Read More
Bayer presents newest angiogenesis inhibitor series
Read More
Substituted aromatic compounds from Takeda inhibit NO production
Read More
Novel alpha1A/1B-adrenoceptor antagonists and use in BPH and pain
Read More
Meiji Seika synthesizes dual integrin and fibrinogen antagonists
Read More
Neurotrophic agents discovered at Teijin presented in recent patent
Read More
Potential new ribonucleotide reductase inhibitors may be more effective than hydroxyurea
Read More